For Asthmapolis, The Name Changes And The Focus Too
This article was originally published in The Gray Sheet
Executive Summary
Digital health startup Asthmapolis has changed its name to Propeller Health, reflecting its broader focus to include chronic obstructive pulmonary disease.
You may also be interested in...
Qualcomm, Novartis Team Up For Remotely Monitored COPD Inhaler
In its continued bid to expand the reach of its 2net connected health system, Qualcomm is working with Novartis to develop a new inhaler for patients with chronic obstructive pulmonary disease that can be used to remotely monitor treatment effectiveness.
Propeller Health Grabs 510(k) Clearance For Bronchodilator Sensor Upgrade
FDA cleared Propeller Health’s newest iteration of its bronchodilator sensor indicated to help monitor and control asthma, COPD, and other respiratory disease.
Digital Health Briefs: Fall Risk Sensors, Asthmapolis Deal, Tooth Sensors
Meta-analysis on the use of sensors in care settings to monitor fall risk shows mixed results. Asthmapolis inks new deal with hospital system. More digital health briefs.